Skip to main content
. Author manuscript; available in PMC: 2018 Feb 13.
Published in final edited form as: Am J Obstet Gynecol. 2017 Mar 16;217(1):57.e1–57.e6. doi: 10.1016/j.ajog.2017.03.005

Table 2. Intrauterine device continuation at 2, 4, and 5 years.

Continuation status All LNG-IUD Cu-IUD Pa
2y .11
Continued 491 (63.6) 412 (64.9) 79 (57.7)
Discontinued 281 (36.4) 223 (35.1) 58 (42.3)
Total 772 635 137
3y <.01
Continued 390 (52.3) 336 (54.7) 54 (41.2)
Discontinued 355 (47.7) 278 (45.3) 77 (58.8)
Total 745 614 131
4y <.01
Continued 307 (42.9) 265 (45.1) 42 (32.6)
Discontinued 409 (57.1) 322 (54.9) 87 (67.4)
Total 716 587 129
5y .33
Continued 187 (27.3) 158 (28.1) 29 (23.8)
Discontinued 498 (72.7) 405 (71.9) 93 (76.2)
Total 685 563 122

Data are presented as n (%) unless otherwise notes and exclude those lost to follow-up at each time point.

CU, copper; IUD, intrauterine device; LNG, levonorgestrel.

a

P compares continuation rates between LNG-IUD and Cu-IUD users.